Navigation Links
Bradmer provides Phase III Neuradiab trial update and guidance
Date:10/15/2007

n of the trial, the Company must present a complete chemistry, manufacturing and controls (CMC) update to the FDA for its review and approval. To facilitate this, Bradmer has submitted a request for an additional guidance meeting with the FDA, during which the Company will detail the technology transfer of the production of Neuradiab from the previous manufacturer to a cGMP commercial facility. Management anticipates that the requested CMC meeting will occur in the near future and the enrollment of patients could begin in late 2007 or in early 2008.

About Bradmer Pharmaceuticals Inc. (http://www.bradmerpharma.com)

Bradmer Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of new and innovative cancer therapies. Bradmer's lead clinical candidate, Neuradiab, was developed at Duke University Medical Center as a proprietary therapy for a particularly aggressive form of brain cancer, glioblastoma multiforme. To date, over US$60 million in grants and related support has driven research and development of the licensed treatment, which has been delivered to over 200 patients with promising results and has completed Phase II clinical trials at Duke University. Bradmer is currently in the process of organizing a prospective multi-center clinical trial of the licensed treatment. Neuradiab has been granted Orphan Drug Status by both the U.S. Food and Drug Administration and the European Medicines Agency.

Bradmer Pharmaceuticals Inc.'s common shares have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state regulatory agency in the United States. The resale or transfer by a U.S. investor of such common shares of Bradmer Pharmaceuticals Inc. is subject to the requirements of Rule 904 of Regulation S of the Securities Act or such other applicable exemption thereunder, and other applicable state securities laws.

'/>"/>
SOURCE Bradmer Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Protein provides antioxidant protection to Neurons
2. Acupuncture provides relief
3. Micro-camera provides new breast imaging technique
4. Hormone therapy provides no heart benefit
5. MicroRNA provides new insight into birth defects
6. Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients
7. Neurobiology Provides Answers To Block Memory-Related Drug Cravings
8. Cholesterol provides immunity against infection by certain parasites
9. John Hopkins CGHH program provides Global Health education
10. London Hospital Provides Specialized Care For Pregnant Women
11. Hope Lodges provides free stay to cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , ... July 29, 2015 , ... ... that seek to help with the problems of substance abuse that face today’s ... Drunk Driving (MADD) to come to their rehabilitation center. The facility, located in ...
(Date:7/29/2015)... ... 29, 2015 , ... Conventional theories used by economists for the past 150 ... able to unlock mysteries about the behavior of microbial life on earth, according to ... University. , The findings, published July 29 in the open access journal PLOS ONE, ...
(Date:7/29/2015)... ... 29, 2015 , ... VideoLink , a leading provider ... in New York, NY, selected the ReadyCam on-site video studio to support their ... immediately access worldwide TV and cable news networks and participate in live TV ...
(Date:7/29/2015)... ... July 29, 2015 , ... Abt Associates has named Selena ... division. In her position, Ramkeesoon will help build and expand work in ... spent close to a decade at ICF International, most recently as a vice ...
(Date:7/29/2015)... ... July 29, 2015 , ... Andrzej Klos, M.D., has been reviewed and approved ... nearly 38 years, is motivated each and every day by his sincere desire to ... alongside his many awards and accolades, which include multiple listings in many highly regarded ...
Breaking Medicine News(10 mins):Health News:MADD Victim Services Specialist Visits A Forever Recovery Rehabilitation Facility 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 3Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 2Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 3Health News:Selena Ramkeesoon Joins Abt Associates as Vice President for Strategic Communications 2Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 2Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 3
... Sept. 2 (HealthDay News) -- Having weight loss surgery before ... have both procedures, according to a small new study. ... first -- including reduced pain and increased ability to exercise ... breasts after they lose large amounts of weight, Dr. Jeffrey ...
... -- A rapid rise in hookah use in California is cause ... used for smoking tobacco. An analysis of state data showed that ... 40 percent between 2005 and 2008. In 2008, hookah use ... percent of men, 10 percent of women) than it was among ...
... (HealthDay News) -- Children,s social goals help determine how ... are effective, researchers say. The new study included ... respond to other students, aggression, how often they were ... created three categories of social goals: wanting to gain ...
... students who practiced on a patient simulator before assisting ... final examinations than did students receiving a lecture only ... of the University of South Florida randomized, controlled trial ... journal Obstetrics & Gynecology. The USF ...
... FRIDAY, Sept. 2 (HealthDay News) -- At age 36, Charles Ruma ... home builder. His diagnosis with testicular cancer came as a shock. ... the older population," Ruma said. "I felt healthy and strong and ... hear those words." , , During his recovery from surgery ...
... , FRIDAY, Sept. 2 (HealthDay News) -- College ... maintaining a healthy lifestyle from day one, an expert says. ... is a great opportunity to establish a healthy lifestyle that ... of medicine at Quinnipiac University School of Medicine in Hamden, ...
Cached Medicine News:Health News:Is Breast Reduction After Weight Loss Surgery Best? 2Health News:Hookah Use Growing Among Young Adults in California 2Health News:Some Kids Seem to Cope Better With Bullying 2Health News:Simulation training in obstetric clerkship improves medical students' examination scores 2Health News:Simulation training in obstetric clerkship improves medical students' examination scores 3Health News:Survivor Builds 'Cancer-Fighting' House 2Health News:Survivor Builds 'Cancer-Fighting' House 3
(Date:7/29/2015)... , July 29, 2015  Depomed, Inc. (NASDAQ: ... that its Board of Directors, after careful consideration ... and legal advisors, has unanimously rejected the purported ... Horizon Pharma plc (NASDAQ: HZNP ) ("Horizon") ... Depomed in an all-stock transaction (the "July 21 ...
(Date:7/29/2015)... 29, 2015 The U.S. Food and Drug ... the ReShape Integrated Dual Balloon System, that may help ... people with obesity and one or more obesity-related conditions, ... Surgery (ASMBS), the nation,s largest organization for bariatric surgeons. ... careful review the FDA has approved this new device ...
(Date:7/29/2015)... SAN DIEGO and WALTHAM, Mass., July 29, ... LLP is investigating whether certain officers ... breached their fiduciary duties to shareholders.  AMAG Pharmaceuticals ... on maternal health, anemia, and cancer supportive care.  ... to reduce the risk of preterm birth in ...
Breaking Medicine Technology:Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 3Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 4Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 5Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 6Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 7Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 8Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 9American Society for Metabolic and Bariatric Surgery Views New Balloon Device For Obesity As Bridge Between Medications And Bariatric Surgery 2American Society for Metabolic and Bariatric Surgery Views New Balloon Device For Obesity As Bridge Between Medications And Bariatric Surgery 3Robbins Arroyo LLP Is Investigating the Officers and Directors of AMAG Pharmaceuticals, Inc. (AMAG) on Behalf of Shareholders 2
... 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: ... biotechnology company focused on researching, developing, manufacturing and ... general meeting of shareholders of 3SBio Inc. will ... a.m., Shenyang time, at our executive office, 15/A-D, ...
... U.S. Food and Drug Administration today approved Adcetris (brentuximab ... lymphoma known as systemic anaplastic large cell lymphoma (ALCL). ... cancers of the lymphatic system. Adcetris is an antibody-drug ... antibody to direct the drug to a target on ...
Cached Medicine Technology:3SBio Inc. to Hold 2011 Annual General Meeting on September 20, 2011 2FDA Approves Adcetris to Treat Two Types of Lymphoma 2FDA Approves Adcetris to Treat Two Types of Lymphoma 3
... temperature set by means of a ... button. A green LED indicates the ... amber LED indicates the unit has ... LED and an audible alarm indicates ...
Provides outstanding patient warming and safety throughout the hospital and is nearly half the size and one-third the weight of earlier units....
The QuickVue Advance® G. vaginalis test is an enzyme activity test for use in the detection of Gardnerella vaginalis Proline IminoPeptidase(PIP) activity in vaginal fluid specimens from women su...
The Affirm™ VPIII tests RNA probe technology offers a dependable, rapid means toward early identification and treatment of patients suffering from these pathogens....
Medicine Products: